NYSDA Publications

FDA Issues Two COVID-19 Updates

The United States Food and Drug Administration (FDA) has issued two updates on the novel coronavirus (COVID-19): 1) authorization of the Pfizer COVID-19 vaccine for persons aged 16 and 17 for booster vaccinations; and 2) an update on the status of COVID-19 tests and the Omicron variant.  To read the FDA authorization of the Pfizer COVID-19 vaccine for persons aged 16 and 17 for booster vaccinations, use the first link below.  To read the FDA update on COVID-19 testing and the Omicron variant, use the second link below.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-booster-dose-16-and-17?utm_medium=email&utm_source=govdelivery  (FDA authorization of Pfizer booster vaccination for persons aged 16 and 17)
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-viral-mutations-impact-covid-19-tests?utm_medium=email&utm_source=govdelivery  (FDA update on COVID-19 testing and Omicron variant)
22380292641